Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK's proprietary AS01E adjuvant.
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of RSV in 2021, according to a ...
Albertans can book appointments for immunization against COVID-19 and RSV beginning today, the province said Monday.
RSV is the most harmful respiratory illness for young infants, says Dr. Jeffrey Pernica, a professor in the Department of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback